Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net loss	$ (1,917,817)	$ (3,671,753)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense		4,860
Stock-based compensation expense included in - General and administrative expenses	14,248	1,150,925
Stock-based compensation expense included in - Research and development expenses		606,901
Foreign currency transaction loss	108,582	30,728
Loss on extinguishment of debt	116,407
Loss on extinguishment of other liabilities	11,154
(Increase) decrease in -
Prepaid expenses	(13,030)	5,599
Increase (decrease) in -
Accounts payable and accrued expenses	456,302	463,510
Accrued compensation and related expenses	836,849	812,874
Notes payable and accrued interest	198,493	75,540
Short-term note payable		24,999
Net cash used in operating activities	(199,966)	(495,817)
Cash flows from financing activities:
Proceeds from sale of common stock units	200,750	476,000
Placement agent and other offering fees	(5,000)	(20,000)
Net cash provided by financing activities	195,750	456,000
Cash and cash equivalents:
Net (decrease) increase	(4,216)	(39,817)
Balance at beginning of period	84,902	92,040
Balance at end of period	80,686	52,223
Supplemental disclosures of cash flow information:
Interest	2,802	2,133
Non-cash financing activities:
10% convertible notes payable, including accrued interest of $62,267, exchanged for common stock	213,266
Accounts payable and accrued expenses extinguished with common stock options	335,529
Officer note payable, exchanged for common stock units	50,000
Accrual of fees payable to placement agent in connection with the sale of common stock units		20,000
Fair value of common stock warrants issued to placement agent in connection with the sale of common stock units		27,648
Reclassification of non-permanent equity		$ 185,000